<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05090475</url>
  </required_header>
  <id_info>
    <org_study_id>hospital A-team_primary care</org_study_id>
    <nct_id>NCT05090475</nct_id>
  </id_info>
  <brief_title>The Implementation of Educational Interventions on the Prescribing of Antimicrobial Drugs in Primary Health Care</brief_title>
  <official_title>The Impact of the Implementation of Educational Interventions Based on Scientific Evidence on the Prescribing of Antimicrobial Drugs in Primary Health Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General Hospital Koprivnica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Koprivnica Križevci County</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Interdisciplinary section for the control of antibiotic resistance (ISKRA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>General Hospital Koprivnica</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      World increase in mortality from consequences of antimicrobial resistance (AMR) represents a&#xD;
      significant public health problem. Irrational prescribing of antimicrobial drugs (AMD) in&#xD;
      general population is one of the main causes of development AMR. This is also contributed by&#xD;
      fact that up to 90% of total antimicrobial consumption in Europe is related to the general&#xD;
      population. Problem of AMR has been recognized by World Health Organization and Council of&#xD;
      European Union, which support the establishment of the antimicrobial stewardship team&#xD;
      (A-team). A-team provides co-ordinated interventions that promote rational use of AMD. To&#xD;
      date, no study has been carried out in which Ateam from hospital environment goes to primary&#xD;
      health care for the purpose of rationalization prescribing of AMD by primary health care&#xD;
      practitioners. Project for implementation of hospital A-team in primary health care in&#xD;
      Koprivnica-Križevci County will be initiated using educational outreach method aimed at&#xD;
      rationalization of the consumption of AMD.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of antimicrobials expressed as DDD per 1000 inhabitants per day for ATC group J01</measure>
    <time_frame>1 year</time_frame>
    <description>Rationalization of general consumption of antimicrobials</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of antimicrobials expressed as DDD per 1000 inhabitants per day for ATC group J01 associated with acute respiratory tract infections</measure>
    <time_frame>1 year</time_frame>
    <description>Rationalization of consumption of antimicrobials for acute respiratory tract infections (for associated ICD diagnoses J01, J02, J03, J06, J20)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Clostridiodes dificile infection for patients on antimicrobial therapy</measure>
    <time_frame>1 year</time_frame>
    <description>Number of Clostridiodes dificile infection for patients on antimicrobial therapy. A case of Clostridioides difficile infection (CDI) is defined as diarrhoeal stools or toxic megacolon and a positive laboratory assay for C. difficile toxin A and/or B in stools or a toxin-producing C. difficile organism detected in stool via culture or other means e.g. a positive PCR result.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of antimicrobials expressed as DDD per 1000 inhabitants per day for ATC group J01 associated with urinary tract infections</measure>
    <time_frame>1 year</time_frame>
    <description>Rationalization of consumption of antimicrobials for urinary tract infections</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Upper Respiratory Tract Infections</condition>
  <condition>Acute Respiratory Tract Infection</condition>
  <condition>Clostridium Difficile Infection</condition>
  <condition>Viral Infection</condition>
  <condition>Bacterial Infections</condition>
  <arm_group>
    <arm_group_label>Hospital A-team led intervention in Koprivnica Križevci County</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hospital A-team will give educational outreach intervention to primary care physicians</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Primary care physicians in Bjelovar Bilogora county will not receive intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Educational outreach intervention</intervention_name>
    <description>Educational outreach or academic detailing is a method based on scientific data with the help of educated A-team members in the form of direct (face-to-face) interactions, prescribing practices change and adherence improves according to the application of currently valid therapeutic guidelines</description>
    <arm_group_label>Hospital A-team led intervention in Koprivnica Križevci County</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All primary care physicians in Koprivnica Križevci County that agree to participate in&#xD;
             the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Primary care physicians outside Koprivnica Križevci County&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Darija Kuruc Poje</last_name>
    <role>Principal Investigator</role>
    <affiliation>General Hospital Koprivnica</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Darija Kuruc Poje</last_name>
    <phone>+38548251501</phone>
    <email>darija_kuruc@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Koprivnica križevci county</name>
      <address>
        <city>Koprivnica</city>
        <state>Koprivnicko-krizevacka</state>
        <zip>48000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Darija Kuruc Poje</last_name>
      <phone>+38548251501</phone>
      <email>darija_kuruc@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Darija Kuruc Poje</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <link>
    <url>https://www.who.int/en/news-room/fact-sheets/detail/antimicrobial-resistance</url>
    <description>WHO Antimicrobial resistance</description>
  </link>
  <link>
    <url>https://amr-review.org/</url>
    <description>Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations. The Review on Antimicrobial Resistance</description>
  </link>
  <link>
    <url>http://www.who.int/medicines/areas/rational_use/PPLreport_2017_09_19.pdf?ua=1</url>
    <description>Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis</description>
  </link>
  <link>
    <url>https://www.ecdc.europa.eu/en/publications-data/antimicrobial-consumption-annual-epidemiological-report-2017</url>
    <description>Antimicrobial consumption - Annual Epidemiological Report for 2017</description>
  </link>
  <link>
    <url>http://www.wpro.who.int/entity/drug_resistance/resources/global_action_plan_eng.pdf,</url>
    <description>Global Action Plan on Antimicrobial Resistance.</description>
  </link>
  <reference>
    <citation>Bryce A, Hay AD, Lane IF, Thornton HV, Wootton M, Costelloe C. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. BMJ. 2016 Mar 15;352:i939. doi: 10.1136/bmj.i939. Review.</citation>
    <PMID>26980184</PMID>
  </reference>
  <reference>
    <citation>Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010 May 18;340:c2096. doi: 10.1136/bmj.c2096. Review.</citation>
    <PMID>20483949</PMID>
  </reference>
  <reference>
    <citation>Marquet K, Liesenborgs A, Bergs J, Vleugels A, Claes N. Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis. Crit Care. 2015 Feb 16;19:63. doi: 10.1186/s13054-015-0795-y. Review.</citation>
    <PMID>25888181</PMID>
  </reference>
  <reference>
    <citation>Teillant A, Gandra S, Barter D, Morgan DJ, Laxminarayan R. Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. Lancet Infect Dis. 2015 Dec;15(12):1429-37. doi: 10.1016/S1473-3099(15)00270-4. Epub 2015 Oct 22. Review.</citation>
    <PMID>26482597</PMID>
  </reference>
  <reference>
    <citation>Bassetti M, Righi E. Development of novel antibacterial drugs to combat multiple resistant organisms. Langenbecks Arch Surg. 2015 Feb;400(2):153-65. doi: 10.1007/s00423-015-1280-4. Epub 2015 Feb 11. Review.</citation>
    <PMID>25667169</PMID>
  </reference>
  <reference>
    <citation>Gundlapalli AV, Beekmann SE, Graham DR, Polgreen PM; Members of the Emerging Infections Network. Antimicrobial Agent Shortages: The New Norm for Infectious Diseases Physicians. Open Forum Infect Dis. 2018 Apr 23;5(4):ofy068. doi: 10.1093/ofid/ofy068. eCollection 2018 Apr.</citation>
    <PMID>29732380</PMID>
  </reference>
  <reference>
    <citation>Nellums LB, Thompson H, Holmes A, Castro-Sánchez E, Otter JA, Norredam M, Friedland JS, Hargreaves S. Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis. Lancet Infect Dis. 2018 Jul;18(7):796-811. doi: 10.1016/S1473-3099(18)30219-6. Epub 2018 May 17.</citation>
    <PMID>29779917</PMID>
  </reference>
  <reference>
    <citation>Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, Farley MM, Dumyati GK, Wilson LE, Beldavs ZG, Dunn JR, Gould LH, MacCannell DR, Gerding DN, McDonald LC, Lessa FC. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med. 2013 Jul 22;173(14):1359-67. doi: 10.1001/jamainternmed.2013.7056.</citation>
    <PMID>23780507</PMID>
  </reference>
  <reference>
    <citation>Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based &quot;detailing&quot;. N Engl J Med. 1983 Jun 16;308(24):1457-63.</citation>
    <PMID>6406886</PMID>
  </reference>
  <reference>
    <citation>Soumerai SB, Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA. 1990 Jan 26;263(4):549-56.</citation>
    <PMID>2104640</PMID>
  </reference>
  <reference>
    <citation>O'Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT, Forsetlund L, Bainbridge D, Freemantle N, Davis DA, Haynes RB, Harvey EL. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD000409. Review.</citation>
    <PMID>17943742</PMID>
  </reference>
  <reference>
    <citation>Meeker D, Linder JA, Fox CR, Friedberg MW, Persell SD, Goldstein NJ, Knight TK, Hay JW, Doctor JN. Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial. JAMA. 2016 Feb 9;315(6):562-70. doi: 10.1001/jama.2016.0275.</citation>
    <PMID>26864410</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2021</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>General Hospital Koprivnica</investigator_affiliation>
    <investigator_full_name>Darija Kuruc Poje</investigator_full_name>
    <investigator_title>Head of hospital pharmacy, Clinical pharmacist</investigator_title>
  </responsible_party>
  <keyword>Antimicrobial resistance</keyword>
  <keyword>Hospital A-team</keyword>
  <keyword>Educational outreach intervention</keyword>
  <keyword>Antimicrobial prescribing</keyword>
  <keyword>Primary care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
    <mesh_term>Bacterial Infections</mesh_term>
    <mesh_term>Clostridium Infections</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Just IPD that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

